ARTICLE | Company News
Cambridge Antibody, Drug Royalty, Inwest Investments Ltd. deal
March 18, 2002 8:00 AM UTC
DRI said its board recommended an offer under which holding company Inwest will acquire DRI for C$3.05 in cash for each DRI share, valuing the deal at C$133 million (US$83.5 million). The board also w...